Literature DB >> 6097354

Interactions between calcium antagonists, calcium fluxes and anthracycline transport.

D Kessel, C Wilberding.   

Abstract

The calcium antagonists verapamil and nifedipine promote responsiveness to anthracyclines in certain drug-resistant cell lines. Their mode of action involves inhibition of anthracycline exodus, leading to promotion of intracellular drug retention. We examined the relationship between calcium fluxes and anthracycline responsiveness in the P388 murine leukemia, and in a drug-resistant sub-line, P388/ADR. Verapamil and nifedipine promoted daunorubicin accumulation by P388/ADR cells, but this occurred regardless of extracellular calcium concentration and did not involve perturbation of calcium transport. We conclude that these agents promote drug retention via mechanisms not related to calcium ion fluxes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097354     DOI: 10.1016/s0304-3835(84)80031-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.

Authors:  S Radel; I Bankusli; E Mayhew; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.

Authors:  A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.

Authors:  E Friche; T Skovsgaard; N I Nissen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.

Authors:  A M Van der Bliek; M B Meyers; J L Biedler; E Hes; P Borst
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

5.  A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

Authors:  P A Philip; S Joel; S C Monkman; E Dolega-Ossowski; K Tonkin; J Carmichael; J R Idle; A L Harris
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.